American College of Cardiology

NOVEMBER 22, 2024

Preventing, detecting and managing cancer therapy-related cardiovascular toxicity (CTR-CVT) is a clear objective during cancer treatment.

Cardio Oncology 40

Cardio Oncology Cancer Article 40

Society of Thoracic Surgeons - Early Career

APRIL 28, 2025

Podcast #9, S1: Rethinking Lung Cancer Screening Eligibility In this episode of Thinking Thoracic , hear from Alexandra Potter, researcher, and Dr. Chi-Fu Jeffrey Yang, both from Massachusetts General Hospital, about a new study that reveals current lung cancer screening guidelines miss nearly half of patients who develop the disease.

Cancer 69

Cancer Hospital Research Outcomes 69

European Journal of Heart Failure

JULY 10, 2025

Aims Cancer therapy-related cardiac dysfunction (CTRCD) can adversely affect clinical outcomes in patients with cancer. This study aimed to evaluate the cardioprotective effects of sacubitril/valsartan in preventing CTRCD in patients with early breast cancer during the first year after adjuvant therapy.

Cancer 45

Cancer Outcomes Research Article 45

Open Heart

JANUARY 21, 2025

Methods The study was based on the Danish Diet, Cancer and Health cohort. Several studies found higher risks of outcomes in individuals with both conditions. Whether the risks of outcomes differ according to temporal order of AF and AMI is unclear.

Myocardial Infarction 52

Myocardial Infarction Atrial Fibrillation Diet Cancer 52

Journal of the American Heart Association

JUNE 23, 2025

BackgroundAlthough early rhythm control (ERC) is effective in reducing stroke in patients with atrial fibrillation (AF), its benefits have not been well elucidated in cancer survivors. During a mean 4‐year follow‐up, stroke occurred in 52 500 patients (1338 cancer survivors and 51 182 noncancer survivors). years; 53.7%

Cancer 45

Cancer Atrial Fibrillation Strokes Stroke 45

Medical Xpress - Cardiology

JUNE 21, 2025

The relationship between genetic variants and the risk of late-onset cardiomyopathy remains poorly understood in survivors of childhood cancer despite being otherwise well established. Scientists from St.

Cancer 65

Cancer Cardiomyopathy Hospital Research 65

Science Daily - Heart Disease

JUNE 12, 2025

Researchers at Johns Hopkins found that fragments of tumor DNA can appear in the bloodstream up to three years before a cancer diagnosis, offering a potentially revolutionary window for early detection and treatment.

Cancer 106

Cancer Research 106

Society of Thoracic Surgeons - Adult Cardiac

JANUARY 26, 2025

With over 95% of adult and congenital cardiac surgery procedures and a majority of lung cancer and esophageal cancer surgery in the US, the data and outcomes from the STS Database specialty registries provide true national benchmarks for clinical outcomes of cardiothoracic surgery.

Aortic valve 83

Aortic valve Cardiothoracic Aortic Congenital 83

Frontiers in Cardiovascular Medicine

JULY 10, 2025

Multiple reports from these studies have consistently shown an inverse and graded association between higher CRF and the incidence of chronic conditions including cardiovascular disease, site-specific cancers, chronic kidney disease, rhythm disturbances, and neurological conditions.

Research 52

Research Chronic Disease Exercise Kidney Disease 52

Frontiers in Cardiovascular Medicine

JULY 18, 2025

This review synthesizes the pathophysiological mechanisms underlying TyG-BMI, alongside its clinical utility and cutting-edge research advancements in hypertension, coronary artery disease, stroke, diabetes, non-alcoholic fatty liver disease, hyperuricemia, and cancer.

BMI 52

BMI Research Coronary Artery Disease Biomarkers 52

American College of Cardiology

JUNE 25, 2025

Among anthracycline and anthraquinone agents, the risk of cancer therapy-related cardiac dysfunction (CTRCD) after treatment for childhood cancer is lower with daunorubicin and higher with mitoxantrone compared with doxorubicin.

Cancer 40

Cancer Article 40

Science Daily - Stroke

MAY 21, 2025

Using a new technique, researchers tracked naturally-occurring 'barcodes' in blood cells which can lead to new strategies that spot early warning signs of unhealthy aging long before symptoms appear, helping prevent cancer or heart disease.

Cancer 60

Cancer Heart Disease Research 60

Frontiers in Cardiovascular Medicine

APRIL 14, 2025

Moreover, the pan-cancer study revealed that these four genes are closely associated with tumor development.ConclusionsOur research identified four unique genes (FCN3, FREM1, MNS1, and SMOC2), enhancing our comprehension of the causes of HF. Meanwhile, three subgroups for patients with HF were identified (C1, C2, and C3).

Heart Failure 52

Heart Failure Cancer Research 52

Open Heart

JUNE 27, 2025

The Palliative Performance Scale (PPS), initially developed for terminally ill cancer patients, has shown prognostic value in various medical settings but remains understudied in cardiac intensive care units (CICUs). This study evaluates the PPS as a prognostic tool for in-hospital and 1-year all-cause mortality in CICU patients.

Chronic Disease 52

Chronic Disease Hospital Cancer 52

Frontiers in Cardiovascular Medicine

FEBRUARY 12, 2025

Sensitivity analyses reconfirmed the robustness of the associations of CVD and hypertension with COPD severity among patients who excluded bronchiectasis, tuberculosis, lung cancer, pulmonary hypertension, pulmonary heart disease, and diabetes (P<0.05).ConclusionThe

Cardiovascular Disease 52

Cardiovascular Disease Pulmonary BMI Hypertension 52

HCPLive

MAY 3, 2025

Compared with non-users, the cannabis use cohort showed significantly greater risks of acute pancreatitis flare pancreatic cancer, and all-cause mortality.

Cancer 75

Cancer Outcomes 75

ADN Center of Excellence

NOVEMBER 14, 2024

Oncology Oncology fellowships delve into cancer care, focusing on advancements in chemotherapy, immunotherapy, and targeted treatments. These programs prepare physicians to lead in the fight against cancer, both in clinical and research settings.

Academic 59

Academic Interventional Cardiology Private Practice Innovation 59

Journal of Clinical Investigation - Cardiology

MAY 1, 2025

Moreover, CD46 has recently emerged as a key player in cancer biology. These features, along with its roles as pathogen receptor, have made CD46 a target for cancer therapeutics. Thus, modified viral vectors (such as strains of adenovirus and measles virus) targeting CD46 currently are being exploited against a wide range of cancers.

Cancer 45

Cancer 45

ADN Center of Excellence

NOVEMBER 7, 2024

Oncology Oncology fellowships are critical for those interested in addressing cancer, one of the most challenging and impactful diseases of our time. Fellows engage in diagnosing, treating, and researching cancers, gaining hands-on experience with cutting-edge treatments and therapies.

Cancer 59

Cancer Academic Research Interventional Cardiology 59

Frontiers in Cardiovascular Medicine

MAY 25, 2025

Numerous studies have demonstrated the part that gut microbiota and its metabolites play in the development and course of several illnesses, including colon cancer, heart failure, stroke, hypertension, and inflammatory bowel disease. Changing the gut microbiota composition has been shown to affect cardiovascular health significantly.

Cardiovascular Disease 52

Cardiovascular Disease Heart Failure Atherosclerosis Hypertension 52

Society of Thoracic Surgeons - Congenital

JANUARY 25, 2025

With over 95% of adult and congenital cardiac surgery procedures and a majority of lung cancer and esophageal cancer surgery in the U.S., The ACSD is part of the STS National Database, one of the largest and most comprehensive clinical registries with nearly 10 million cardiothoracic procedures performed by 4,300+ surgeons.

Aortic valve 75

Aortic valve Aortic Cardiothoracic Cancer 75

DAIC

JANUARY 24, 2025

With over 95% of adult and congenital cardiac surgery procedures and a majority of lung cancer and esophageal cancer surgery in the U.S., The STS National Database, one of the largest and most comprehensive clinical registries with nearly 10 million cardiothoracic procedures performed by 4,300+ surgeons.

Outcomes 52

Outcomes Coronary Artery Bypass Graft Cardiothoracic Medicare 52

DAIC

APRIL 29, 2025

With nearly 10 million cardiothoracic procedures submitted by more than 4,300 surgeons, the STS Database captures over 95% of adult and congenital cardiac surgery procedures performed in the United States, along with a majority of lung and esophageal cancer surgeries.

Aortic 52

Aortic Coronary Artery Bypass Graft Aortic valve Cardiothoracic 52

DAIC

JANUARY 28, 2025

Studying and understanding biological development is not only essential for improving the clinical management of congenital diseases but is also foundational for many other biomedical areas, such as cancer and regenerative medicine. The researchers say that the clipping spline is ready to be widely used by the biomedical imaging community.

Research 52

Research Congenital Technology Congenital Heart Disease 52

DAIC

OCTOBER 30, 2024

30, 2024 — HeartLung Technologies , a developer of AI tools for early detection of heart disease, lung cancer and other conditions announced that its AI-enabled Automated Cardiac Chambers Volumetry (AutoChamber) recently received “Breakthrough Medical Device” designation and marketing authorization from the U.S. added Dr. Naghavi.

Cancer 45

Cancer Heart Failure Sudden Cardiac Death Atrial Fibrillation 45

Frontiers in Cardiovascular Medicine

DECEMBER 11, 2024

BackgroundCardiovascular biomarkers are crucial for monitoring cancer therapy-related cardiac toxicity, but the effects on early stage are still inadequate. The ROC curves showed that sST2, NT-proBNP, and sST2+NT-proBNP had good predictive value for arrhythmia (areas under the curves were 0.631, 0.633, and 0.735, respectively, P<0.05).ConclusionsEarly

Cancer 52

Cancer Arrhythmia Biomarkers Research 52

Medical Xpress - Cardiology

JUNE 5, 2025

A new study from researchers at Mass General Brigham has found that a higher McCance Brain Care Score not only associates with the risk of brain-related conditions such as stroke, dementia, and depression but also strongly associates with developing cardiovascular disease and three common types of cancer.

Cardiovascular Disease 40

Cardiovascular Disease Cancer Dementia Research 40

American College of Cardiology

FEBRUARY 1, 2025

These include hypertensive disorders of pregnancy, early or premature menopause, gestational diabetes, polycystic ovarian syndrome, autoimmune or other inflammatory diseases, and breast cancer therapies. These have ranged from heart attacks, cardio-obstetrics, breast cancer, prevention and arrhythmias.8-13 Circulation. Circulation.

Cardiovascular Disease 45

Cardiovascular Disease Education Coronary Artery Disease Risk Factors 45

Journal of Clinical Investigation - Cardiology

MAY 1, 2025

Divergent integration site profiles reflected differential gene expression patterns of naive and memory T cells.CONCLUSION These results demonstrate that HIV persisted in both naive and memory CD4+ T cells that underwent clonal expansion and harbored intact proviruses, and suggest that infected memory T cell clones do not frequently arise from naive (..)

Cancer 40

Cancer Research 40

Journal of Clinical Investigation - Cardiology

FEBRUARY 3, 2025

Disruption of the balance may lead to inflammatory bowel diseases and even colorectal cancer (CRC). Various factors play key roles in maintaining intestine homeostasis. Loss or gain of function of many key proteins can result in dysregulated intestinal homeostasis.

Cancer 65

Cancer Research 65

CardiacWire

FEBRUARY 12, 2025

Anthos LILAC trial is focused on preventing stroke and systemic embolism in AFib patients, while ASTER and MAGNOLIA aim to use abelacimab to address VTE and GI cancer. Novartis abelacimab efforts will now take a unique clinical approach since the Anthos-designed phase 3 trials focus on more than just ischemic stroke.

AFIB 102

AFIB Plaque Embolism Strokes 102

HCPLive

MAY 24, 2025

Elizabeth Hale, MD, discusses the need to improve awareness and diagnosis of actinic keratosis.

Cancer 52

Cancer 52

Dr. Paddy Barrett

NOVEMBER 1, 2024

When you compare those in the highest fitness levels to those in the lowest fitness levels, the impact on early death, death from heart disease and cancer deaths is incredible 1. Cancer deaths: 43% reduction in risk. Cancer deaths: 7% reduction in risk. Death from any cause: 53% reduction in risk.

Exercise 119

Exercise Quality of Life Heart Disease Blood Pressure 119

Open Heart

JUNE 27, 2025

No cardiac-related cancer cases were reported in any group, but longer follow-up is needed to assess potential oncogenic risks. Stem cell therapy was associated with fewer adverse events than controls (OR 0.66, 95% CI 0.44 to 0.99, p=0.05), supporting its short-term to mid-term safety.

Myocardial Infarction 52

Myocardial Infarction Cancer Heart Failure Article 52

Journal of Clinical Investigation - Cardiology

JANUARY 2, 2025

Cancer patients undergoing chemotherapy often experience anorexia and weight loss that substantially deteriorates overall health, reduces treatment tolerance and quality of life, and worsens oncologic outcomes. There are currently few effective therapeutic options to mitigate these side effects.

Quality of Life 86

Quality of Life Cancer Outcomes 86

Circulation

DECEMBER 3, 2024

Similarly, smokeless tobacco has the potential to increase the risk of oral cancer, but the risks depend on the chemical composition of the product. The use of some types of these products, for instance, is associated with an increased mortality risk in those with ischemic heart or cerebrovascular disease.

Cardiovascular Disease 73

Cardiovascular Disease Cerebrovascular Disease Pharmacology Biomarkers 73

Frontiers in Cardiovascular Medicine

APRIL 28, 2025

This case report discussed a 43-year-old female who underwent multiple radiotherapy sessions after cervical cancer surgery and experienced serious complications due to simultaneous iliac vein stent placement immediately after thrombus aspiration without adequate evaluation of the indication for stent placement.

Stents 52

Stents Stent Thrombosis Cancer 52